A new wave of scientific interest is spotlighting GOT2—glutamic-oxaloacetic transaminase 2—as a compelling therapeutic target ...

A TRANSAMINASE, accomplishing the transfer of amino-nitrogen from 1-ornithine to the ketonic acids, pyruvic, oxalacetic and α-ketoglutaric acid, occurs in mammalian and avian liver. There is ...

The tirzepatide-only treatment group did not exhibit transaminase elevations, according to the company. CEO Kristen Fortney said, "We made the difficult decision to discontinue the STRIDES Phase 2 ...